Free Trial

Texas Instruments (TXN) Financials

Texas Instruments logo
$309.84 +9.32 (+3.10%)
Closing price 03:59 PM Eastern
Extended Trading
$309.85 +0.01 (+0.00%)
As of 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Texas Instruments

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2,944 3,551 3,649 5,538 4,986 5,568 7,736 8,710 6,477 4,775 4,973
Consolidated Net Income / (Loss)
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Net Income / (Loss) Continuing Operations
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Total Pre-Tax Income
4,216 4,930 6,080 6,686 5,728 6,017 8,919 10,032 7,418 5,453 5,710
Total Operating Income
4,322 4,855 6,083 6,713 5,723 5,894 8,960 10,140 7,331 5,465 6,023
Total Gross Profit
7,575 8,257 9,614 10,277 9,164 9,269 12,376 13,771 11,019 9,094 10,083
Total Revenue
13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641 17,682
Operating Revenue
13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641 17,682
Total Cost of Revenue
5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547 7,599
Operating Cost of Revenue
5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547 7,599
Total Operating Expenses
3,253 3,402 3,531 3,564 3,441 3,375 3,416 3,631 3,688 3,629 4,060
Selling, General & Admin Expense
1,728 1,742 1,694 1,684 1,645 1,647 1,720 1,704 1,825 1,794 1,860
Research & Development Expense
1,267 1,356 1,508 1,559 1,544 1,530 1,554 1,670 1,863 1,959 2,083
Restructuring Charge
258 304 329 321 -36 - - 257 0.00 -124 117
Total Other Income / (Expense), net
-106 75 -3.00 -27 5.00 123 -41 -108 87 -12 -313
Interest Expense
90 80 78 125 170 190 184 214 353 508 543
Other Income / (Expense), net
-16 155 75 98 175 313 143 106 440 496 230
Income Tax Expense
1,230 1,335 2,398 1,106 711 422 1,150 1,283 908 654 709
Preferred Stock Dividends Declared
42 44 33 42 31 27 33 39 33 24 28
Basic Earnings per Share
$2.86 $3.54 $3.68 $5.71 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24 $5.47
Weighted Average Basic Shares Outstanding
1.03B 1.00B 991M 970M 936M 921M 923M 916M 908M 912M 909M
Diluted Earnings per Share
$2.82 $3.48 $3.61 $5.59 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20 $5.45
Weighted Average Diluted Shares Outstanding
1.04B 1.02B 1.01B 990M 952M 933M 936M 926M 916M 919M 913M
Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 991.60M 969.90M 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M 907.55M
Cash Dividends to Common per Share
$1.40 - $2.12 $2.63 $3.21 $3.72 $4.21 $4.69 $5.02 $5.26 $5.50

Quarterly Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
1,100 1,121 1,355 1,199 1,173 1,288 1,356 1,156 1,536 1,969 2,411
Consolidated Net Income / (Loss)
1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545 1,980 2,425
Net Income / (Loss) Continuing Operations
1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545 1,980 2,425
Total Pre-Tax Income
1,293 1,247 1,554 1,359 1,276 1,478 1,584 1,372 1,714 2,238 2,805
Total Operating Income
1,286 1,248 1,554 1,377 1,324 1,563 1,663 1,473 1,808 2,310 2,874
Total Gross Profit
2,095 2,211 2,474 2,314 2,313 2,575 2,723 2,472 2,799 3,352 3,887
Total Revenue
3,661 3,822 4,151 4,007 4,069 4,448 4,742 4,423 4,825 5,463 6,055
Operating Revenue
3,661 3,822 4,151 4,007 4,069 4,448 4,742 4,423 4,825 5,463 6,055
Total Cost of Revenue
1,566 1,611 1,677 1,693 1,756 1,873 2,019 1,951 2,026 2,111 2,168
Operating Cost of Revenue
1,566 1,611 1,677 1,693 1,756 1,873 2,019 1,951 2,026 2,111 2,168
Total Operating Expenses
809 963 920 937 989 1,012 1,060 999 991 1,042 1,013
Selling, General & Admin Expense
455 465 428 446 472 485 457 446 464 490 476
Research & Development Expense
478 498 492 491 517 527 518 521 510 535 530
Restructuring Charge
-124 0.00 0.00 - 0.00 0.00 85 32 17 17 7.00
Total Other Income / (Expense), net
7.00 -1.00 0.00 -18 -48 -85 -79 -101 -94 -72 -69
Interest Expense
116 131 131 130 128 133 141 141 141 141 141
Other Income / (Expense), net
123 130 131 112 80 48 62 40 47 69 72
Income Tax Expense
188 120 192 154 97 183 220 209 169 258 380
Preferred Stock Dividends Declared
5.00 6.00 7.00 6.00 6.00 7.00 8.00 7.00 9.00 11 14
Basic Earnings per Share
$1.21 $1.23 $1.48 $1.32 $1.29 $1.42 $1.49 $1.27 $1.69 $2.16 $2.64
Weighted Average Basic Shares Outstanding
910M 912M 913M 912M 910M 908M 909M 909M 909M 912M 914M
Diluted Earnings per Share
$1.20 $1.22 $1.47 $1.31 $1.28 $1.41 $1.48 $1.28 $1.68 $2.14 $2.62
Weighted Average Diluted Shares Outstanding
917M 919M 920M 919M 916M 912M 914M 913M 914M 920M 921M
Weighted Average Basic & Diluted Shares Outstanding
910.48M 913.05M 912.22M 910.33M 908.47M 909.14M 908.62M 907.55M 910.09M 913.25M 913.77M

Annual Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-199 154 502 782 -1.00 670 1,524 -1,581 -86 236 25
Net Cash From Operating Activities
4,397 4,614 5,363 7,189 6,649 6,139 8,756 8,720 6,420 6,318 7,153
Net Cash From Continuing Operating Activities
4,397 4,614 5,366 7,189 6,649 6,139 8,756 8,720 6,420 6,318 7,153
Net Income / (Loss) Continuing Operations
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Consolidated Net Income / (Loss)
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Depreciation Expense
766 605 539 590 708 733 755 925 1,175 1,508 1,918
Amortization Expense
367 350 365 364 342 259 199 54 63 72 81
Non-Cash Adjustments To Reconcile Net Income
201 212 242 229 194 220 173 286 362 260 421
Changes in Operating Assets and Liabilities, net
100 -148 538 426 388 -668 -140 -1,294 -1,690 -321 -268
Net Cash From Investing Activities
-302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202 -1,439
Net Cash From Continuing Investing Activities
-302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202 -1,439
Purchase of Property, Plant & Equipment
-551 -531 -695 -1,131 -847 -649 -2,462 -2,797 -5,071 -4,820 -4,550
Purchase of Investments
-2,767 -3,503 -4,555 -5,641 -3,444 -5,786 -10,124 -14,483 -12,705 -9,716 -3,524
Sale of Property, Plant & Equipment
110 0.00 40 9.00 30 4.00 75 3.00 3.00 195 1.00
Sale and/or Maturity of Investments
2,892 3,390 4,095 6,708 2,309 5,545 8,478 13,657 13,387 11,187 6,308
Other Investing Activities, net
14 -6.00 -12 -23 32 -36 -62 37 24 -48 326
Net Cash From Financing Activities
-4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880 -5,689
Net Cash From Continuing Financing Activities
-4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880 -5,689
Repayment of Debt
-1,003 -1,003 -656 -547 -792 -536 -596 -541 -557 -653 -812
Repurchase of Common Equity
-2,741 -2,132 -2,556 -5,100 -2,960 -2,553 -527 -3,615 -293 -929 -1,477
Payment of Dividends
-1,444 -1,646 -2,104 -2,555 -3,008 -3,426 -3,886 -4,297 -4,557 -4,795 -4,999
Issuance of Debt
498 499 1,099 1,500 1,491 1,498 1,495 1,494 3,000 2,980 1,199
Issuance of Common Equity
396 472 483 373 539 470 377 241 263 517 400

Quarterly Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-481 257 -151 611 -437 281 267 -86 324 111 551
Net Cash From Operating Activities
1,017 1,571 1,732 1,998 849 1,860 2,190 2,254 1,520 2,703 3,419
Net Cash From Continuing Operating Activities
1,017 1,571 1,732 1,998 849 1,860 2,190 2,254 1,520 2,703 3,419
Net Income / (Loss) Continuing Operations
1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545 1,980 2,425
Consolidated Net Income / (Loss)
1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545 1,980 2,425
Depreciation Expense
346 363 383 416 424 460 497 537 541 547 555
Amortization Expense
16 18 19 19 20 21 20 20 21 21 21
Non-Cash Adjustments To Reconcile Net Income
-23 119 87 77 116 129 93 83 104 119 95
Changes in Operating Assets and Liabilities, net
-427 -56 -119 281 -890 -45 216 451 -691 36 323
Net Cash From Investing Activities
-3,329 - -487 614 1,253 -1,335 -681 -676 -47 -1,702 -987
Net Cash From Continuing Investing Activities
-3,329 - -487 614 1,253 -1,335 -681 -676 -47 -1,702 -987
Purchase of Property, Plant & Equipment
-1,248 -1,064 -1,316 -1,192 -1,123 -1,305 -1,197 -925 -676 -514 -463
Purchase of Investments
-4,864 -2,098 -1,845 -909 -647 -1,192 -805 -880 -935 -2,407 -1,969
Sale and/or Maturity of Investments
2,631 3,130 2,700 2,726 2,807 1,131 1,260 1,110 1,043 636 1,399
Other Investing Activities, net
-40 30 -26 -12 216 31 60 19 516 551 46
Net Cash From Financing Activities
1,831 -1,314 -1,396 -2,001 -2,539 -244 -1,242 -1,664 -1,149 -890 -1,881
Net Cash From Continuing Financing Activities
1,831 -1,314 -1,396 -2,001 -2,539 -244 -1,242 -1,664 -1,149 -890 -1,881
Repayment of Debt
-28 -306 -8.00 -311 -766 -21 -12 -13 -9.00 -13 -551
Repurchase of Common Equity
-3.00 -71 -318 -537 -653 -302 -119 -403 -158 -27 -48
Payment of Dividends
-1,183 -1,185 -1,187 -1,240 -1,238 -1,235 -1,236 -1,290 -1,291 -1,295 -1,298
Issuance of Common Equity
65 248 117 87 118 115 125 42 309 445 16

Annual Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509 34,585
Total Current Assets
7,074 7,457 8,734 8,097 8,761 10,239 13,685 14,021 15,122 15,026 13,750
Cash & Equivalents
1,000 1,154 1,656 2,438 2,437 3,107 4,631 3,050 2,964 3,200 3,225
Short-Term Investments
2,218 2,336 2,813 1,795 2,950 3,461 5,108 6,017 5,611 4,380 1,656
Accounts Receivable
1,165 1,267 1,278 1,207 1,074 1,414 1,701 1,895 1,787 1,719 1,963
Inventories, net
1,691 1,790 1,957 2,217 2,001 1,955 1,910 2,757 3,999 4,527 4,804
Prepaid Expenses
1,000 910 1,030 440 299 302 335 302 761 1,200 2,102
Plant, Property, & Equipment, net
2,596 2,512 2,664 3,183 3,303 3,269 5,141 6,876 9,999 11,347 12,320
Plant, Property & Equipment, gross
5,465 4,923 4,789 5,425 5,740 5,781 7,858 9,950 13,268 15,254 17,682
Accumulated Depreciation
2,869 2,411 2,125 2,242 2,437 2,512 2,717 3,074 3,269 3,907 5,362
Total Noncurrent Assets
6,560 6,462 6,244 5,857 5,954 5,843 5,850 6,310 7,227 9,136 8,515
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,330
Intangible Assets
1,629 1,316 1,056 717 409 122 85 152 223 257 238
Noncurrent Deferred & Refundable Income Taxes
201 374 264 295 197 343 263 473 757 936 967
Employee Benefit Assets
85 96 208 92 218 246 392 188 173 233 324
Other Noncurrent Operating Assets
62 79 86 140 468 770 748 1,135 1,712 3,348 2,656
Total Liabilities & Shareholders' Equity
16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509 34,585
Total Liabilities
6,284 5,958 7,305 8,143 9,111 10,164 11,343 12,630 15,451 18,606 18,312
Total Current Liabilities
2,555 2,264 2,258 2,474 2,123 2,390 2,569 2,985 3,320 3,643 3,159
Short-Term Debt
1,000 631 500 749 500 550 500 500 599 750 500
Accounts Payable
386 396 466 478 388 415 571 851 802 820 756
Current Deferred & Payable Income Tax Liabilities
95 83 128 103 46 134 121 189 172 159 67
Current Employee Benefit Liabilities
664 710 722 724 714 767 775 799 836 839 829
Other Current Liabilities
410 444 442 420 475 524 602 646 911 1,075 1,007
Total Noncurrent Liabilities
3,729 3,694 5,047 5,669 6,988 7,774 8,774 9,645 12,131 14,963 15,153
Long-Term Debt
3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846 13,548
Noncurrent Deferred & Payable Income Tax Liabilities
37 33 78 42 78 90 87 66 63 53 66
Noncurrent Employee Benefit Liabilities
196 129 89 118 93 131 79 118 108 110 124
Other Noncurrent Operating Liabilities
- 554 1,303 1,190 1,514 1,305 1,367 1,226 1,336 1,954 1,415
Total Equity & Noncontrolling Interests
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Total Preferred & Common Equity
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Common Stock
3,370 3,415 3,517 3,691 3,851 4,074 4,371 4,692 5,103 5,676 6,252
Retained Earnings
31,176 33,107 34,662 37,906 39,898 42,051 45,919 50,353 52,283 52,262 52,236
Treasury Stock
-24,068 -25,523 -27,458 -32,130 -34,495 -36,578 -36,800 -40,214 -40,284 -40,895 -42,130
Accumulated Other Comprehensive Income / (Loss)
-532 -526 -384 -473 -347 -360 -157 -254 -205 -140 -85

Quarterly Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
32,348 34,885 35,048 35,321 35,509 33,757 34,933 35,004 34,393 35,882 36,839
Total Current Assets
15,122 17,448 16,789 15,872 15,026 13,086 14,484 13,876 13,796 15,757 16,880
Cash & Equivalents
2,964 2,483 2,740 2,589 3,200 2,763 3,044 3,311 3,549 3,660 4,211
Short-Term Investments
5,611 7,910 6,948 6,163 4,380 2,242 2,315 1,875 1,554 3,341 3,931
Accounts Receivable
1,787 1,671 1,711 1,862 1,719 1,860 1,934 2,062 2,245 2,520 2,620
Inventories, net
3,999 4,083 4,106 4,296 4,527 4,687 4,812 4,829 4,695 4,605 4,672
Prepaid Expenses
761 1,301 1,284 962 1,200 1,534 2,379 1,799 1,753 1,631 1,446
Plant, Property, & Equipment, net
9,999 10,442 11,174 11,802 11,347 11,811 12,321 12,348 12,145 11,911 11,833
Plant, Property & Equipment, gross
13,268 13,739 14,622 15,464 15,254 16,036 16,878 17,314 17,870 17,856 18,072
Accumulated Depreciation
3,269 3,297 3,448 3,662 3,907 4,225 4,557 4,966 5,725 5,945 6,239
Total Noncurrent Assets
7,227 6,995 7,085 7,647 9,136 8,860 8,128 8,780 8,452 8,214 8,126
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,330 4,330 4,330
Intangible Assets
223 231 230 229 257 263 248 237 323 314 301
Noncurrent Deferred & Refundable Income Taxes
757 821 905 941 936 1,030 1,096 1,089 973 1,017 1,054
Employee Benefit Assets
173 169 167 184 233 240 253 251 321 316 320
Other Noncurrent Operating Assets
1,712 1,412 1,421 1,931 3,348 2,965 2,169 2,841 2,505 2,237 2,121
Total Liabilities & Shareholders' Equity
32,348 34,885 35,048 35,321 35,509 33,757 34,933 35,004 34,393 35,882 36,839
Total Liabilities
15,451 17,902 17,834 18,053 18,606 17,351 18,530 18,377 17,615 17,875 17,654
Total Current Liabilities
3,320 3,553 3,637 3,686 3,643 2,489 2,492 3,118 3,096 3,244 3,017
Short-Term Debt
599 1,349 1,049 1,049 750 0.00 0.00 500 1,149 1,149 650
Accounts Payable
802 551 858 794 820 866 881 779 638 680 837
Current Deferred & Payable Income Tax Liabilities
172 378 178 108 159 284 53 79 138 70 60
Current Employee Benefit Liabilities
836 399 569 721 839 418 595 724 389 536 675
Other Current Liabilities
911 876 983 1,014 1,075 921 963 1,036 782 809 795
Total Noncurrent Liabilities
12,131 14,349 14,197 14,367 14,963 14,862 16,038 15,259 14,519 14,631 14,637
Long-Term Debt
10,624 12,840 12,842 12,844 12,846 12,848 14,043 13,546 12,901 12,903 12,905
Noncurrent Deferred & Payable Income Tax Liabilities
63 55 55 54 53 56 63 60 63 55 62
Noncurrent Employee Benefit Liabilities
108 111 113 117 110 115 122 125 121 123 118
Other Noncurrent Operating Liabilities
1,336 1,343 1,187 1,352 1,954 1,843 1,810 1,528 1,434 1,550 1,552
Total Equity & Noncontrolling Interests
16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778 18,007 19,185
Total Preferred & Common Equity
16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778 18,007 19,185
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778 18,007 19,185
Common Stock
5,103 5,180 5,407 5,554 5,676 5,799 5,986 6,151 6,463 6,870 6,943
Retained Earnings
52,283 52,199 52,135 52,304 52,262 52,196 52,249 52,369 52,483 53,161 54,282
Treasury Stock
-40,284 -40,193 -40,128 -40,395 -40,895 -41,442 -41,676 -41,744 -42,084 -41,941 -41,955
Accumulated Other Comprehensive Income / (Loss)
-205 -203 -200 -195 -140 -147 -156 -149 -84 -83 -85

Annual Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.35% 2.85% 11.90% 5.50% -8.88% 0.54% 26.85% 9.18% -12.53% -10.72% 13.05%
EBITDA Growth
4.64% 9.67% 18.39% 9.95% -10.52% 3.61% 39.70% 11.61% -19.74% -16.29% 9.43%
EBIT Growth
8.52% 16.35% 22.91% 10.60% -13.40% 5.24% 46.66% 12.56% -24.16% -23.29% 4.90%
NOPAT Growth
6.50% 15.66% 4.05% 52.09% -10.53% 9.34% 42.41% 13.31% -27.25% -25.24% 9.68%
Net Income Growth
5.85% 20.40% 2.42% 51.55% -10.09% 11.52% 38.86% 12.61% -25.59% -26.28% 4.21%
EPS Growth
9.73% 23.40% 3.74% 54.85% -6.26% 13.93% 38.36% 13.92% -24.87% -26.45% 4.81%
Operating Cash Flow Growth
8.46% 4.94% 16.23% 34.05% -7.51% -7.67% 42.63% -0.41% -26.38% -1.59% 13.22%
Free Cash Flow Firm Growth
4.29% 3.26% 14.53% 30.65% -2.35% -8.64% 15.73% 0.79% -80.89% 26.63% 91.85%
Invested Capital Growth
-5.59% -2.54% -6.57% -1.02% -5.79% 4.37% 20.37% 25.67% 37.21% 17.26% 11.00%
Revenue Q/Q Growth
-0.61% 1.71% 2.30% -0.21% -2.49% 5.29% 4.30% -0.80% -3.27% -0.45% 2.41%
EBITDA Q/Q Growth
0.15% 5.69% 0.74% -0.09% -3.29% 10.19% 5.31% -2.05% -5.33% -0.78% 1.80%
EBIT Q/Q Growth
1.22% 7.63% 0.90% -0.47% -3.86% 12.16% 6.27% -2.71% -6.96% -2.57% 0.39%
NOPAT Q/Q Growth
1.24% 1.49% -13.48% 19.11% -3.60% 10.47% 8.09% -2.23% -8.68% -2.77% 0.54%
Net Income Q/Q Growth
0.37% 6.24% -16.03% 19.10% -3.26% 12.42% 6.15% -1.97% -8.32% -3.34% -0.83%
EPS Q/Q Growth
1.81% 6.75% -15.65% 19.44% -2.42% 12.64% 6.03% -1.36% -8.30% -3.53% -0.55%
Operating Cash Flow Q/Q Growth
2.93% -3.59% 11.24% 3.10% -5.55% 6.43% 2.72% -3.49% -1.80% 1.19% 3.71%
Free Cash Flow Firm Q/Q Growth
2.97% -7.35% 11.44% 5.96% -6.75% 5.42% -11.73% 2.31% -24.14% -0.48% 27.00%
Invested Capital Q/Q Growth
-4.70% -1.61% -10.97% -6.02% -4.22% -1.46% 12.14% 6.67% 3.39% 2.28% -0.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.27% 61.76% 64.26% 65.11% 63.71% 64.10% 67.47% 68.76% 62.90% 58.14% 57.02%
EBITDA Margin
41.84% 44.61% 47.20% 49.20% 48.31% 49.78% 54.82% 56.05% 51.42% 48.21% 46.67%
Operating Margin
33.25% 36.31% 40.66% 42.53% 39.79% 40.76% 48.84% 50.63% 41.85% 34.94% 34.06%
EBIT Margin
33.12% 37.47% 41.16% 43.15% 41.01% 42.92% 49.62% 51.16% 44.36% 38.11% 35.36%
Profit (Net Income) Margin
22.97% 26.89% 24.61% 35.35% 34.88% 38.69% 42.35% 43.68% 37.16% 30.68% 28.28%
Tax Burden Percent
70.83% 72.92% 60.56% 83.46% 87.59% 92.99% 87.11% 87.21% 87.76% 88.01% 87.58%
Interest Burden Percent
97.91% 98.40% 98.73% 98.16% 97.12% 96.94% 97.98% 97.91% 95.46% 91.48% 91.32%
Effective Tax Rate
29.17% 27.08% 39.44% 16.54% 12.41% 7.01% 12.89% 12.79% 12.24% 11.99% 12.42%
Return on Invested Capital (ROIC)
27.98% 33.74% 36.78% 58.19% 53.90% 59.44% 75.22% 69.14% 38.08% 22.65% 21.82%
ROIC Less NNEP Spread (ROIC-NNEP)
18.27% 53.10% 37.24% 117.49% 55.15% 125.55% 79.26% 77.23% 44.67% 22.41% 18.21%
Return on Net Nonoperating Assets (RNNOA)
1.39% 1.47% -1.39% -0.46% 2.16% 2.40% -6.22% -6.45% 3.29% 5.74% 8.33%
Return on Equity (ROE)
29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40% 30.15%
Cash Return on Invested Capital (CROIC)
33.73% 36.32% 43.56% 59.22% 59.86% 55.17% 56.73% 46.39% 6.71% 6.76% 11.39%
Operating Return on Assets (OROA)
25.63% 30.68% 36.15% 39.17% 33.55% 33.22% 41.35% 39.50% 26.10% 17.57% 17.84%
Return on Assets (ROA)
17.77% 22.01% 21.61% 32.09% 28.54% 29.94% 35.29% 33.73% 21.86% 14.14% 14.27%
Return on Common Equity (ROCE)
29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40% 30.15%
Return on Equity Simple (ROE_SIMPLE)
30.02% 34.33% 35.62% 62.04% 56.33% 60.90% 58.27% 60.02% 38.53% 28.39% 0.00%
Net Operating Profit after Tax (NOPAT)
3,061 3,540 3,684 5,603 5,013 5,481 7,805 8,843 6,434 4,810 5,275
NOPAT Margin
23.55% 26.48% 24.62% 35.50% 34.85% 37.90% 42.55% 44.15% 36.72% 30.75% 29.83%
Net Nonoperating Expense Percent (NNEP)
9.71% -19.36% -0.47% -59.30% -1.25% -66.11% -4.04% -8.08% -6.59% 0.24% 3.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 37.93% 22.88% 15.77% 17.40%
Cost of Revenue to Revenue
41.73% 38.24% 35.74% 34.89% 36.29% 35.90% 32.53% 31.24% 37.10% 41.86% 42.98%
SG&A Expenses to Revenue
13.29% 13.03% 11.32% 10.67% 11.44% 11.39% 9.38% 8.51% 10.42% 11.47% 10.52%
R&D to Revenue
9.75% 10.14% 10.08% 9.88% 10.73% 10.58% 8.47% 8.34% 10.63% 12.52% 11.78%
Operating Expenses to Revenue
25.02% 25.45% 23.60% 22.58% 23.92% 23.34% 18.62% 18.13% 21.05% 23.20% 22.96%
Earnings before Interest and Taxes (EBIT)
4,306 5,010 6,158 6,811 5,898 6,207 9,103 10,246 7,771 5,961 6,253
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5,439 5,965 7,062 7,765 6,948 7,199 10,057 11,225 9,009 7,541 8,252
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.41 5.64 8.27 8.60 11.79 14.79 12.05 9.63 8.84 10.05 9.62
Price to Tangible Book Value (P/TBV)
11.09 12.32 17.38 19.75 25.40 28.88 18.08 13.94 12.14 13.82 13.38
Price to Revenue (P/Rev)
3.37 4.42 5.71 4.90 7.30 9.39 8.76 7.01 8.53 10.86 8.86
Price to Earnings (P/E)
14.90 16.63 23.42 13.96 21.07 24.40 20.76 16.11 23.07 35.56 31.49
Dividend Yield
3.24% 2.77% 2.44% 3.27% 2.86% 2.51% 2.42% 3.03% 3.05% 2.83% 3.19%
Earnings Yield
6.71% 6.01% 4.27% 7.16% 4.75% 4.10% 4.82% 6.21% 4.33% 2.81% 3.18%
Enterprise Value to Invested Capital (EV/IC)
4.19 5.69 8.76 8.14 11.65 14.45 13.99 9.83 7.78 7.67 6.52
Enterprise Value to Revenue (EV/Rev)
3.43 4.41 5.67 4.94 7.31 9.41 8.65 6.99 8.68 11.24 9.38
Enterprise Value to EBITDA (EV/EBITDA)
8.19 9.88 12.01 10.03 15.13 18.90 15.77 12.47 16.88 23.31 20.09
Enterprise Value to EBIT (EV/EBIT)
10.34 11.77 13.77 11.44 17.83 21.92 17.43 13.66 19.57 29.49 26.51
Enterprise Value to NOPAT (EV/NOPAT)
14.55 16.65 23.02 13.91 20.98 24.83 20.32 15.83 23.64 36.55 31.43
Enterprise Value to Operating Cash Flow (EV/OCF)
10.13 12.78 15.82 10.84 15.81 22.16 18.12 16.05 23.69 27.83 23.18
Enterprise Value to Free Cash Flow (EV/FCFF)
12.07 15.47 19.44 13.67 18.89 26.75 26.95 23.59 134.14 122.47 60.19
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.41 0.34 0.39 0.56 0.65 0.74 0.58 0.60 0.66 0.80 0.86
Long-Term Debt to Equity
0.31 0.28 0.35 0.48 0.60 0.68 0.54 0.56 0.63 0.76 0.83
Financial Leverage
0.08 0.03 -0.04 0.00 0.04 0.02 -0.08 -0.08 0.07 0.26 0.46
Leverage Ratio
1.65 1.60 1.64 1.80 1.96 2.07 1.96 1.86 1.89 2.01 2.11
Compound Leverage Factor
1.62 1.57 1.62 1.77 1.91 2.00 1.92 1.82 1.81 1.84 1.93
Debt to Total Capital
29.29% 25.63% 28.29% 36.04% 39.45% 42.53% 36.73% 37.47% 39.91% 44.58% 46.33%
Short-Term Debt to Total Capital
7.11% 4.48% 3.47% 5.33% 3.40% 3.44% 2.37% 2.14% 2.13% 2.46% 1.65%
Long-Term Debt to Total Capital
22.18% 21.15% 24.82% 30.71% 36.05% 39.09% 34.36% 35.33% 37.78% 42.12% 44.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.71% 74.37% 71.72% 63.96% 60.55% 57.47% 63.27% 62.53% 60.09% 55.42% 53.67%
Debt to EBITDA
0.76 0.61 0.58 0.65 0.84 0.94 0.77 0.78 1.25 1.80 1.70
Net Debt to EBITDA
0.13 -0.02 -0.09 0.08 0.02 0.03 -0.20 -0.03 0.29 0.80 1.11
Long-Term Debt to EBITDA
0.57 0.50 0.51 0.56 0.76 0.87 0.72 0.73 1.18 1.70 1.64
Debt to NOPAT
1.35 1.02 1.11 0.90 1.16 1.24 0.99 0.99 1.74 2.83 2.66
Net Debt to NOPAT
0.22 -0.03 -0.18 0.10 0.02 0.04 -0.26 -0.04 0.41 1.25 1.74
Long-Term Debt to NOPAT
1.02 0.84 0.97 0.77 1.06 1.14 0.93 0.93 1.65 2.67 2.57
Altman Z-Score
8.89 10.97 12.21 11.42 12.34 13.35 13.60 11.72 9.84 8.92 8.72
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.77 3.29 3.87 3.27 4.13 4.28 5.33 4.70 4.55 4.12 4.35
Quick Ratio
1.72 2.10 2.55 2.20 3.04 3.34 4.45 3.67 3.12 2.55 2.17
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,690 3,810 4,364 5,702 5,568 5,087 5,887 5,933 1,134 1,436 2,754
Operating Cash Flow to CapEx
997.05% 868.93% 818.78% 640.73% 813.83% 951.78% 366.82% 312.10% 126.68% 136.61% 157.24%
Free Cash Flow to Firm to Interest Expense
41.00 47.63 55.95 45.61 32.75 26.77 31.99 27.73 3.21 2.83 5.07
Operating Cash Flow to Interest Expense
48.86 57.68 68.76 57.51 39.11 32.31 47.59 40.75 18.19 12.44 13.17
Operating Cash Flow Less CapEx to Interest Expense
43.96 51.04 60.36 48.54 34.31 28.92 34.61 27.69 3.83 3.33 4.80
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.77 0.82 0.88 0.91 0.82 0.77 0.83 0.77 0.59 0.46 0.50
Accounts Receivable Turnover
10.78 11.00 11.76 12.70 12.61 11.62 11.78 11.14 9.52 8.92 9.60
Inventory Turnover
3.12 2.94 2.85 2.64 2.47 2.62 3.09 2.68 1.92 1.54 1.63
Fixed Asset Turnover
4.78 5.23 5.78 5.40 4.44 4.40 4.36 3.33 2.08 1.47 1.49
Accounts Payable Turnover
13.18 13.08 12.41 11.67 12.05 12.93 12.11 8.80 7.86 8.07 9.64
Days Sales Outstanding (DSO)
33.85 33.20 31.04 28.73 28.94 31.40 30.99 32.77 38.36 40.91 38.00
Days Inventory Outstanding (DIO)
116.90 124.25 127.89 138.32 147.50 139.05 118.19 136.12 189.69 237.67 224.10
Days Payable Outstanding (DPO)
27.69 27.91 29.42 31.28 30.28 28.23 30.15 41.48 46.41 45.21 37.85
Cash Conversion Cycle (CCC)
123.06 129.53 129.51 135.77 146.16 142.23 119.03 127.42 181.63 233.36 224.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,627 10,357 9,677 9,578 9,023 9,417 11,335 14,245 19,545 22,919 25,440
Invested Capital Turnover
1.19 1.27 1.49 1.64 1.55 1.57 1.77 1.57 1.04 0.74 0.73
Increase / (Decrease) in Invested Capital
-629 -270 -680 -99 -555 394 1,918 2,910 5,300 3,374 2,521
Enterprise Value (EV)
44,534 58,954 84,816 77,917 105,150 136,070 158,627 139,990 152,067 175,810 165,782
Market Capitalization
43,853 59,070 85,476 77,333 105,034 135,840 160,625 140,322 149,419 169,794 156,615
Book Value per Share
$9.80 $10.48 $10.49 $9.36 $9.53 $10.01 $14.44 $16.06 $18.60 $18.53 $17.91
Tangible Book Value per Share
$3.90 $4.80 $4.99 $4.08 $4.42 $5.12 $9.62 $11.09 $13.56 $13.47 $12.88
Total Capital
14,066 14,082 14,414 14,062 14,710 15,985 21,074 23,312 28,120 30,499 30,321
Total Debt
4,120 3,609 4,077 5,068 5,803 6,798 7,741 8,735 11,223 13,596 14,048
Total Long-Term Debt
3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846 13,548
Net Debt
681 -116 -660 584 116 230 -1,998 -332 2,648 6,016 9,167
Capital Expenditures (CapEx)
441 531 655 1,122 817 645 2,387 2,794 5,068 4,625 4,549
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,301 2,334 2,507 2,139 1,751 1,831 1,877 2,469 3,826 4,553 6,210
Debt-free Net Working Capital (DFNWC)
5,519 5,824 6,976 6,372 7,138 8,399 11,616 11,536 12,401 12,133 11,091
Net Working Capital (NWC)
4,519 5,193 6,476 5,623 6,638 7,849 11,116 11,036 11,802 11,383 10,591
Net Nonoperating Expense (NNE)
75 -55 1.82 23 -4.38 -114 36 94 -76 11 274
Net Nonoperating Obligations (NNO)
681 -116 -660 584 116 230 -1,998 -332 2,648 6,016 9,167
Total Depreciation and Amortization (D&A)
1,133 955 904 954 1,050 992 954 979 1,238 1,580 1,999
Debt-free, Cash-free Net Working Capital to Revenue
17.70% 17.46% 16.76% 13.55% 12.17% 12.66% 10.23% 12.33% 21.84% 29.11% 35.12%
Debt-free Net Working Capital to Revenue
42.45% 43.56% 46.63% 40.37% 49.63% 58.08% 63.32% 57.60% 70.79% 77.57% 62.72%
Net Working Capital to Revenue
34.76% 38.84% 43.29% 35.62% 46.15% 54.28% 60.60% 55.10% 67.37% 72.78% 59.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24 $5.47
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 936M 921M 923M 916M 908M 912M 909M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20 $5.45
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 952M 933M 936M 926M 916M 919M 913M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M 907.55M
Normalized Net Operating Profit after Tax (NOPAT)
3,244 3,762 3,883 5,870 4,981 5,481 7,805 9,067 6,434 4,700 5,378
Normalized NOPAT Margin
24.95% 28.14% 25.95% 37.19% 34.63% 37.90% 42.55% 45.27% 36.72% 30.05% 30.41%
Pre Tax Income Margin
32.43% 36.87% 40.64% 42.36% 39.82% 41.61% 48.62% 50.09% 42.34% 34.86% 32.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
47.84 62.63 78.95 54.49 34.69 32.67 49.47 47.88 22.01 11.73 11.52
NOPAT to Interest Expense
34.01 44.25 47.23 44.82 29.49 28.85 42.42 41.32 18.23 9.47 9.71
EBIT Less CapEx to Interest Expense
42.94 55.99 70.55 45.51 29.89 29.27 36.50 34.82 7.66 2.63 3.14
NOPAT Less CapEx to Interest Expense
29.11 37.62 38.83 35.84 24.68 25.45 29.44 28.27 3.87 0.36 1.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
48.36% 45.79% 57.14% 45.79% 59.96% 61.23% 50.02% 49.11% 70.00% 99.92% 99.96%
Augmented Payout Ratio
140.15% 105.09% 126.56% 137.19% 118.96% 106.86% 56.80% 90.43% 74.50% 119.27% 129.49%

Quarterly Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 907,550,774.00 910,092,791.00 913,247,686.00
DEI Adjusted Shares Outstanding
- - - - - - - - 907,550,774.00 910,092,791.00 913,247,686.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.69 2.16 2.64
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.40% -15.65% -8.41% -1.72% 11.14% 16.38% 14.24% 10.38% 18.58% 22.82% 27.69%
EBITDA Growth
-22.83% -26.43% -10.81% -2.98% 4.35% 18.93% 7.43% 7.59% 30.79% 40.87% 57.09%
EBIT Growth
-30.04% -34.10% -16.58% -9.54% -0.35% 16.91% 2.37% 1.61% 32.12% 47.67% 70.78%
NOPAT Growth
-35.26% -33.50% -19.04% -10.07% 11.31% 21.42% 5.14% 2.27% 33.22% 49.23% 73.51%
Net Income Growth
-35.30% -34.55% -20.30% -12.11% 6.70% 14.91% 0.15% -3.49% 31.04% 52.90% 77.79%
EPS Growth
-35.14% -34.76% -20.54% -12.67% 6.67% 15.57% 0.68% -2.29% 31.25% 51.77% 77.03%
Operating Cash Flow Growth
-12.33% 12.29% -10.58% 3.85% -16.52% 18.40% 26.44% 12.81% 79.03% 45.32% 56.12%
Free Cash Flow Firm Growth
-75.87% 9.44% 44.63% 45.39% 41.74% 14.23% 23.16% 40.90% 106.84% 190.10% 304.96%
Invested Capital Growth
31.31% 21.64% 18.53% 17.26% 16.70% 17.14% 13.74% 11.00% 6.09% -0.12% -3.49%
Revenue Q/Q Growth
-10.20% 4.40% 8.61% -3.47% 1.55% 9.31% 6.61% -6.73% 9.09% 13.22% 10.84%
EBITDA Q/Q Growth
-10.69% -0.68% 18.65% -7.81% -3.95% 13.20% 7.17% -7.67% 16.76% 21.93% 19.51%
EBIT Q/Q Growth
-14.40% -2.20% 22.28% -11.63% -5.71% 14.74% 7.08% -12.29% 22.60% 28.25% 23.83%
NOPAT Q/Q Growth
-19.05% 2.63% 20.76% -10.36% 0.20% 11.94% 4.57% -12.81% 30.52% 25.40% 21.58%
Net Income Q/Q Growth
-19.40% 1.99% 20.85% -11.53% -2.16% 9.84% 5.33% -14.74% 32.85% 28.16% 22.47%
EPS Q/Q Growth
-20.00% 1.67% 20.49% -10.88% -2.29% 10.16% 4.96% -13.51% 31.25% 27.38% 22.43%
Operating Cash Flow Q/Q Growth
-47.14% 54.47% 10.25% 15.36% -57.51% 119.08% 17.74% 2.92% -32.56% 77.83% 26.49%
Free Cash Flow Firm Q/Q Growth
2.19% 30.44% 20.14% -0.52% -4.35% -2.40% 28.45% 22.70% 112.08% 1,248.26% 62.77%
Invested Capital Q/Q Growth
6.31% 3.07% 4.63% 2.28% 5.80% 3.46% 1.59% -0.18% 1.12% -2.59% -1.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
57.22% 57.85% 59.60% 57.75% 56.84% 57.89% 57.42% 55.89% 58.01% 61.36% 64.19%
EBITDA Margin
48.37% 46.02% 50.28% 48.02% 45.42% 47.03% 47.28% 46.80% 50.09% 53.94% 58.17%
Operating Margin
35.13% 32.65% 37.44% 34.36% 32.54% 35.14% 35.07% 33.30% 37.47% 42.28% 47.46%
EBIT Margin
38.49% 36.05% 40.59% 37.16% 34.50% 36.22% 36.38% 34.21% 38.45% 43.55% 48.65%
Profit (Net Income) Margin
30.18% 29.49% 32.81% 30.07% 28.98% 29.11% 28.76% 26.29% 32.02% 36.24% 40.05%
Tax Burden Percent
85.46% 90.38% 87.64% 88.67% 92.40% 87.62% 86.11% 84.77% 90.14% 88.47% 86.45%
Interest Burden Percent
91.77% 90.49% 92.23% 91.27% 90.88% 91.74% 91.83% 90.68% 92.40% 94.07% 95.21%
Effective Tax Rate
14.54% 9.62% 12.36% 11.33% 7.60% 12.38% 13.89% 15.23% 9.86% 11.53% 13.55%
Return on Invested Capital (ROIC)
27.56% 24.34% 24.96% 22.45% 21.43% 22.08% 21.77% 20.64% 24.92% 29.03% 34.03%
ROIC Less NNEP Spread (ROIC-NNEP)
27.83% 24.31% 24.96% 22.08% 20.67% 20.92% 20.80% 19.52% 23.91% 28.22% 33.19%
Return on Net Nonoperating Assets (RNNOA)
3.78% 4.30% 5.46% 5.66% 7.21% 8.02% 8.59% 8.93% 12.10% 12.90% 13.23%
Return on Equity (ROE)
31.34% 28.64% 30.41% 28.11% 28.64% 30.10% 30.36% 29.58% 37.02% 41.93% 47.26%
Cash Return on Invested Capital (CROIC)
4.81% 7.47% 6.98% 6.76% 6.50% 6.47% 9.06% 11.39% 16.83% 25.46% 33.13%
Operating Return on Assets (OROA)
20.17% 17.58% 19.05% 17.13% 16.13% 17.26% 17.86% 17.26% 20.80% 23.93% 28.13%
Return on Assets (ROA)
15.82% 14.38% 15.40% 13.86% 13.55% 13.87% 14.12% 13.27% 17.33% 19.91% 23.15%
Return on Common Equity (ROCE)
31.34% 28.64% 30.41% 28.11% 28.64% 30.10% 30.36% 29.58% 37.02% 41.93% 47.26%
Return on Equity Simple (ROE_SIMPLE)
34.78% 30.86% 28.75% 0.00% 29.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,099 1,128 1,362 1,221 1,223 1,369 1,432 1,249 1,630 2,044 2,485
NOPAT Margin
30.02% 29.51% 32.81% 30.47% 30.07% 30.79% 30.20% 28.23% 33.78% 37.41% 41.03%
Net Nonoperating Expense Percent (NNEP)
-0.27% 0.03% 0.00% 0.37% 0.76% 1.16% 0.97% 1.13% 1.01% 0.81% 0.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - 4.00% 4.18% 4.50% 4.67% 4.12% 5.29% 6.37% 7.59%
Cost of Revenue to Revenue
42.78% 42.15% 40.40% 42.25% 43.16% 42.11% 42.58% 44.11% 41.99% 38.64% 35.81%
SG&A Expenses to Revenue
12.43% 12.17% 10.31% 11.13% 11.60% 10.90% 9.64% 10.08% 9.62% 8.97% 7.86%
R&D to Revenue
13.06% 13.03% 11.85% 12.25% 12.71% 11.85% 10.92% 11.78% 10.57% 9.79% 8.75%
Operating Expenses to Revenue
22.10% 25.20% 22.16% 23.38% 24.31% 22.75% 22.35% 22.59% 20.54% 19.07% 16.73%
Earnings before Interest and Taxes (EBIT)
1,409 1,378 1,685 1,489 1,404 1,611 1,725 1,513 1,855 2,379 2,946
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,771 1,759 2,087 1,924 1,848 2,092 2,242 2,070 2,417 2,947 3,522
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.19 10.22 10.92 10.05 9.97 11.50 10.05 9.62 10.50 15.06 13.33
Price to Tangible Book Value (P/TBV)
12.60 13.94 14.88 13.82 13.89 15.99 13.89 13.38 14.53 20.30 17.58
Price to Revenue (P/Rev)
9.29 10.94 12.00 10.86 10.19 11.31 9.67 8.86 9.56 13.95 12.32
Price to Earnings (P/E)
26.55 33.30 38.17 35.56 33.74 37.61 33.30 31.49 33.02 45.08 36.17
Dividend Yield
2.96% 2.66% 2.52% 2.83% 2.96% 2.59% 2.96% 3.19% 2.86% 1.89% 2.03%
Earnings Yield
3.77% 3.00% 2.62% 2.81% 2.96% 2.66% 3.00% 3.18% 3.03% 2.22% 2.76%
Enterprise Value to Invested Capital (EV/IC)
7.69 8.41 8.65 7.67 7.07 7.86 6.90 6.52 7.20 11.11 10.62
Enterprise Value to Revenue (EV/Rev)
9.52 11.20 12.33 11.24 10.68 11.83 10.19 9.38 10.04 14.31 12.58
Enterprise Value to EBITDA (EV/EBITDA)
18.84 22.94 25.49 23.31 22.50 24.81 21.70 20.09 20.99 28.76 23.84
Enterprise Value to EBIT (EV/EBIT)
22.31 27.92 31.67 29.49 28.78 31.88 28.24 26.51 27.62 37.25 30.05
Enterprise Value to NOPAT (EV/NOPAT)
27.40 34.21 39.17 36.55 34.75 38.12 33.53 31.43 32.59 43.79 35.26
Enterprise Value to Operating Cash Flow (EV/OCF)
25.47 27.94 31.03 27.83 27.87 30.64 25.50 23.18 23.66 32.11 26.40
Enterprise Value to Free Cash Flow (EV/FCFF)
181.58 123.67 134.31 122.47 117.17 131.07 81.11 60.19 44.03 43.60 31.49
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.84 0.81 0.80 0.80 0.78 0.86 0.84 0.86 0.84 0.78 0.71
Long-Term Debt to Equity
0.76 0.75 0.74 0.76 0.78 0.86 0.81 0.83 0.77 0.72 0.67
Financial Leverage
0.14 0.18 0.22 0.26 0.35 0.38 0.41 0.46 0.51 0.46 0.40
Leverage Ratio
1.99 1.99 1.98 2.01 2.06 2.08 2.07 2.11 2.05 2.06 2.01
Compound Leverage Factor
1.83 1.80 1.82 1.83 1.87 1.91 1.91 1.92 1.90 1.94 1.91
Debt to Total Capital
45.52% 44.66% 44.58% 44.58% 43.92% 46.12% 45.79% 46.33% 45.58% 43.83% 41.40%
Short-Term Debt to Total Capital
4.33% 3.37% 3.37% 2.46% 0.00% 0.00% 1.63% 1.65% 3.73% 3.58% 1.99%
Long-Term Debt to Total Capital
41.19% 41.29% 41.22% 42.12% 43.92% 46.12% 44.16% 44.68% 41.85% 40.25% 39.42%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
54.48% 55.34% 55.42% 55.42% 56.08% 53.88% 54.21% 53.67% 54.42% 56.17% 58.60%
Debt to EBITDA
1.67 1.77 1.83 1.80 1.69 1.77 1.73 1.70 1.59 1.45 1.24
Net Debt to EBITDA
0.45 0.54 0.68 0.80 1.03 1.09 1.09 1.11 1.01 0.73 0.49
Long-Term Debt to EBITDA
1.51 1.64 1.69 1.70 1.69 1.77 1.67 1.64 1.46 1.33 1.18
Debt to NOPAT
2.43 2.64 2.81 2.83 2.60 2.71 2.68 2.66 2.47 2.21 1.83
Net Debt to NOPAT
0.65 0.80 1.04 1.25 1.59 1.68 1.69 1.74 1.58 1.11 0.73
Long-Term Debt to NOPAT
2.20 2.44 2.60 2.67 2.60 2.71 2.58 2.57 2.27 2.03 1.74
Altman Z-Score
8.42 9.04 9.36 8.50 8.81 9.24 8.57 8.27 9.23 12.36 12.04
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.91 4.62 4.31 4.12 5.26 5.81 4.45 4.35 4.46 4.86 5.60
Quick Ratio
3.40 3.13 2.88 2.55 2.76 2.93 2.32 2.17 2.37 2.94 3.57
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,856 -2,682 -2,142 -2,153 -2,247 -2,301 -1,646 -1,272 154 2,073 3,374
Operating Cash Flow to CapEx
96.31% 147.93% 131.61% 167.76% 75.60% 142.53% 183.11% 243.68% 226.53% 560.79% 738.44%
Free Cash Flow to Firm to Interest Expense
-33.24 -20.47 -16.35 -16.56 -17.55 -17.30 -11.67 -9.02 1.09 14.70 23.93
Operating Cash Flow to Interest Expense
8.77 11.99 13.22 15.37 6.63 13.99 15.53 15.99 10.78 19.17 24.25
Operating Cash Flow Less CapEx to Interest Expense
-0.34 3.89 3.18 6.21 -2.14 4.17 7.05 9.43 6.02 15.75 20.96
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.49 0.47 0.46 0.47 0.48 0.49 0.50 0.54 0.55 0.58
Accounts Receivable Turnover
9.47 8.78 8.19 8.92 9.09 9.15 8.80 9.60 8.98 8.74 8.87
Inventory Turnover
1.78 1.67 1.58 1.54 1.54 1.57 1.61 1.63 1.68 1.72 1.74
Fixed Asset Turnover
1.86 1.63 1.49 1.47 1.44 1.42 1.43 1.49 1.54 1.61 1.72
Accounts Payable Turnover
8.72 7.34 8.63 8.07 9.51 8.05 9.33 9.64 10.46 10.39 10.22
Days Sales Outstanding (DSO)
38.54 41.59 44.58 40.91 40.15 39.89 41.48 38.00 40.63 41.79 41.15
Days Inventory Outstanding (DIO)
205.38 218.64 230.34 237.67 237.57 232.54 226.85 224.10 217.59 211.99 210.02
Days Payable Outstanding (DPO)
41.88 49.70 42.31 45.21 38.39 45.34 39.11 37.85 34.88 35.14 35.72
Cash Conversion Cycle (CCC)
202.04 210.53 232.61 233.36 239.34 227.09 229.22 224.25 223.34 218.64 215.45
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
20,779 21,417 22,409 22,919 24,249 25,087 25,487 25,440 25,725 25,058 24,598
Invested Capital Turnover
0.92 0.82 0.76 0.74 0.71 0.72 0.72 0.73 0.74 0.78 0.83
Increase / (Decrease) in Invested Capital
4,955 3,810 3,504 3,374 3,470 3,670 3,078 2,521 1,476 -29 -889
Enterprise Value (EV)
159,866 180,174 193,749 175,810 171,430 197,301 175,896 165,782 185,139 278,322 261,205
Market Capitalization
156,070 175,971 188,608 169,794 163,587 188,617 167,036 156,615 176,192 271,271 255,792
Book Value per Share
$18.66 $18.91 $18.91 $18.53 $18.02 $18.06 $18.29 $17.91 $18.49 $19.79 $21.01
Tangible Book Value per Share
$13.62 $13.86 $13.88 $13.47 $12.94 $12.98 $13.23 $12.88 $13.36 $14.68 $15.94
Total Capital
31,172 31,105 31,161 30,499 29,254 30,446 30,673 30,321 30,828 32,059 32,740
Total Debt
14,189 13,891 13,893 13,596 12,848 14,043 14,046 14,048 14,050 14,052 13,555
Total Long-Term Debt
12,840 12,842 12,844 12,846 12,848 14,043 13,546 13,548 12,901 12,903 12,905
Net Debt
3,796 4,203 5,141 6,016 7,843 8,684 8,860 9,167 8,947 7,051 5,413
Capital Expenditures (CapEx)
1,056 1,062 1,316 1,191 1,123 1,305 1,196 925 671 482 463
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,851 4,513 4,483 4,553 5,592 6,633 6,072 6,210 6,746 6,661 6,371
Debt-free Net Working Capital (DFNWC)
15,244 14,201 13,235 12,133 10,597 11,992 11,258 11,091 11,849 13,662 14,513
Net Working Capital (NWC)
13,895 13,152 12,186 11,383 10,597 11,992 10,758 10,591 10,700 12,513 13,863
Net Nonoperating Expense (NNE)
-5.98 0.90 0.00 16 44 74 68 86 85 64 60
Net Nonoperating Obligations (NNO)
3,796 4,203 5,141 6,016 7,843 8,684 8,860 9,167 8,947 7,051 5,413
Total Depreciation and Amortization (D&A)
362 381 402 435 444 481 517 557 562 568 576
Debt-free, Cash-free Net Working Capital to Revenue
28.87% 28.05% 28.53% 29.11% 34.84% 39.78% 35.17% 35.12% 36.59% 34.24% 30.68%
Debt-free Net Working Capital to Revenue
90.73% 88.25% 84.24% 77.57% 66.03% 71.92% 65.20% 62.72% 64.26% 70.23% 69.89%
Net Working Capital to Revenue
82.70% 81.73% 77.56% 72.78% 66.03% 71.92% 62.31% 59.90% 58.03% 64.32% 66.76%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.21 $1.23 $1.48 $1.32 $1.29 $1.42 $1.49 $1.27 $1.69 $2.16 $2.64
Adjusted Weighted Average Basic Shares Outstanding
910M 912M 913M 912M 910M 908M 909M 909M 909M 912M 914M
Adjusted Diluted Earnings per Share
$1.20 $1.22 $1.47 $1.31 $1.28 $1.41 $1.48 $1.28 $1.68 $2.14 $2.62
Adjusted Weighted Average Diluted Shares Outstanding
917M 919M 920M 919M 916M 912M 914M 913M 914M 920M 921M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
910.48M 913.05M 912.22M 910.33M 908.47M 909.14M 908.62M 907.55M 910.09M 913.25M 913.77M
Normalized Net Operating Profit after Tax (NOPAT)
993 1,128 1,362 1,221 1,223 1,369 1,505 1,276 1,645 2,059 2,491
Normalized NOPAT Margin
27.13% 29.51% 32.81% 30.47% 30.07% 30.79% 31.74% 28.84% 34.09% 37.69% 41.13%
Pre Tax Income Margin
35.32% 32.63% 37.44% 33.92% 31.36% 33.23% 33.40% 31.02% 35.52% 40.97% 46.33%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
12.15 10.52 12.86 11.45 10.97 12.11 12.23 10.73 13.16 16.87 20.89
NOPAT to Interest Expense
9.47 8.61 10.40 9.39 9.56 10.30 10.16 8.86 11.56 14.49 17.62
EBIT Less CapEx to Interest Expense
3.04 2.41 2.82 2.29 2.20 2.30 3.75 4.17 8.40 13.45 17.61
NOPAT Less CapEx to Interest Expense
0.37 0.50 0.35 0.23 0.78 0.48 1.67 2.30 6.80 11.08 14.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
78.13% 88.01% 95.39% 99.92% 99.53% 97.20% 98.14% 99.96% 94.13% 84.47% 72.74%
Augmented Payout Ratio
81.40% 91.49% 104.59% 119.27% 131.93% 133.11% 130.08% 129.49% 112.43% 96.15% 81.68%

Financials Breakdown Chart

Key Financial Trends

Texas Instruments (NASDAQ: TXN) showed a sharp improvement in its latest quarter. Q2 2026 revenue increased to $5.46 billion, up 23% from $4.45 billion in Q2 2025 and 13% sequentially. Net income rose 53% year over year to $1.98 billion, while operating income increased 48% to $2.31 billion. Gross margin also improved to approximately 61.4%, compared with 57.9% a year earlier.

The improvement extended to cash generation. Operating cash flow reached $2.70 billion in Q2 2026, up from $1.86 billion in Q2 2025. Capital expenditures declined to $514 million from $1.31 billion, producing estimated free cash flow of approximately $2.19 billion. This compares with roughly $555 million a year earlier. The latest result also represents a significant recovery from the weaker cash flow and earnings levels reported during 2024 and early 2025.

TXN’s balance sheet remains liquid, although its financial structure has changed as the company has invested heavily in manufacturing capacity. Cash and short-term investments totaled $7.00 billion at the end of Q2 2026, while total debt stood at approximately $14.05 billion. Net property, plant and equipment has grown from $8.53 billion in Q2 2023 to $11.91 billion, indicating continued investment in production capacity. Investors should also note that the supplied historical figures include several restated or calculated periods, so comparisons should be viewed as directional.

  • Strong earnings recovery: Q2 2026 net income increased 53% year over year, and diluted EPS rose to $2.14 from $1.41.
  • Improving operating leverage: Revenue grew faster than operating expenses, lifting operating margin to approximately 42.3% from 35.1% in Q2 2025.
  • Higher-quality cash generation: Operating cash flow increased 45% year over year, while lower capital spending drove a substantial improvement in estimated free cash flow.
  • Healthy liquidity: Cash and short-term investments increased to $7.00 billion from $5.36 billion in Q2 2025, supporting dividends and ongoing investment.
  • Working-capital improvement: Q2 operating assets and liabilities provided $36 million of cash, a notable improvement from the $691 million use of cash in Q1 2026.
  • Capacity expansion remains substantial: Gross property, plant and equipment increased to $17.86 billion from $11.66 billion in Q2 2023, which could support future growth but requires sustained demand and utilization.
  • Share count is relatively stable: Diluted shares outstanding were 920 million in Q2 2026 versus 912 million in Q2 2025, limiting the benefit of recent repurchases.
  • High shareholder distributions: TXN paid $1.30 billion in dividends during Q2 2026, representing roughly 65% of net income for the quarter and contributing to negative financing cash flow.
  • Debt remains elevated: Total debt was approximately $14.05 billion, compared with $11.20 billion in Q2 2023. Interest expense of $141 million also remains a recurring drag on pretax earnings.
  • Balance-sheet efficiency bears watching: Accounts receivable increased to $2.52 billion from $1.93 billion a year earlier, and current liabilities rose to $3.24 billion from $2.49 billion, creating additional working-capital and liquidity considerations.
11/11/26 01:20 PM ETAI Generated. May Contain Errors.

Texas Instruments Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Texas Instruments' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $5.00 billion in 2025, rising from $2.99 billion in 2015. The previous period was $4.80 billion in 2024. See Texas Instruments' forecast for analyst expectations on what's next for the company.

Texas Instruments' total operating income in 2025 was $6.02 billion, based on the following breakdown:
  • Total Gross Profit: $10.08 billion
  • Total Operating Expenses: $4.06 billion

Over the last 10 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $17.68 billion in 2025, a change of 36.0%.

In the past 11 quarters, Texas Instruments' cash and equivalents has ranged from $2.48 billion in Q1 2024 to $4.21 billion in Q3 2026, and is currently $4.21 billion as of their latest financial filing in Q3 2026.

Texas Instruments had total debt of $14.05 billion at the end of 2025, a 3.3% increase from 2024, and a 241.0% increase since 2015.

Over the last 10 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 17.91 in 2025, a change of 82.7%.



Financial statements for NASDAQ:TXN last updated on 10/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners